Yaxley, W. J., McBean, R., Wong, D., Grimes, D., Vasey, P., Frydenberg, M., & Yaxley, J. W. (2021). Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer? Korean Urological Association.
Style de citation Chicago (17e éd.)Yaxley, William John, Rhiannon McBean, David Wong, David Grimes, Paul Vasey, Mark Frydenberg, et John William Yaxley. Should Lutetium-prostate Specific Membrane Antigen Radioligand Therapy for Metastatic Prostate Cancer Be Used Earlier in Men with Lymph Node Only Metastatic Prostate Cancer? Korean Urological Association, 2021.
Style de citation MLA (8e éd.)Yaxley, William John, et al. Should Lutetium-prostate Specific Membrane Antigen Radioligand Therapy for Metastatic Prostate Cancer Be Used Earlier in Men with Lymph Node Only Metastatic Prostate Cancer? Korean Urological Association, 2021.